Ocular Therapeutix, Inc. (OCUL)

7.78 +0.75 (+10.67%) USD  |  NASDAQ  |  Feb 20, 16:00
7.68 -0.10 (-1.29%) After-Hours: 20:00
More

Ocular Therapeutix Long Term Deferred Tax Assets (Quarterly)

Long Term Deferred Tax Assets (Quarterly) Chart

View Long Term Deferred Tax Assets (Quarterly) for OCUL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Long Term Deferred Tax Assets (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Long Term Deferred Tax Assets (Quarterly) Range, Past 5 Years

View Long Term Deferred Tax Assets (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Long Term Deferred Tax Assets (Quarterly) Benchmarks

View Long Term Deferred Tax Assets (Quarterly) Benchmarks
Start Trial
Regeneron Pharmaceuticals, Inc. Upgrade
Boston Scientific Corp. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade
EyePoint Plc --
Vertex Pharmaceuticals, Inc. Upgrade